Postoperative Mortality Rates following Total Gastrectomy for Gastric Cancer: Experience of a Single Surgical Team
- Authors
-
-
R.B. Bayramov
Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan -
R.T. Abdullayeva
Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan -
S.E. Huseynova
Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan -
F.R. Bayramli
Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan
-
- Keywords:
- Gastric cancer, gastrectomy, total gastrectomy, esophagojejunal anastomosis, anastomotic leakage
- Abstract
-
Objective: Total gastrectomy is a complex surgical procedure that is characterized by significant postoperative morbidity and mortality rates and the patients may continue to experience adverse events beyond the standard 30-day follow-up period after surgery. The aim of this study is to investigate postoperative complication and 30-day/90-day mortality rates following total gastrectomy in a cohort of patients and highlight the possible ways that can improve the short-term outcome of this surgical procedure.
Material and Methods: 401 patients underwent total gastrectomy for gastric carcinoma by a single surgical team from January 2001 till December 2021. The patients stratified in 3 groups based on the time period when surgery was performed, hospital- and treatment-related objective factors: group I (61 patients); group II (163 patients) and group III (177 patients).
Results: Esophagojejunal anastomotic leakage rate varied with periods and ranged from 1.1% to 3.3%, 1.7% in total. Differences were insignificant in complication and death rates between the patients aged ≤70 years and > 70 years (p>0.05). Postoperative death rate within 90 days was higher by 42% compared to that in standard 30-day follow-up period. Neaodjuvant chemotherapy was not found to be associated with an increased rate of 30-day postoperative mortality (p>0.05).
Conclusion(s): Total gastrectomy for gastric cancer may be associated with minimal rates of esophagojejunal anastomotic leakage and mortality when performed by specialized and experienced high-volume surgeons. 90-day mortality rate after total gastrectomy is 42% higher compared to 30-day mortality that warrants more intense monitoring of the relevant patients within 3 months after surgery.
- References
-
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49. https://doi.org/10.3322/caac.21660
Ciesielski M, Kruszewski WJ, Szajewski M, et al. Extremely High Mortality Rate after a Successful Gastrectomy for Cancer in Older Adults. Gastric Cancer 2019; 19: 201-11. https://doi.org/10.5230/jgc.2019.19.e16
The Dutch Upper Gastrointestinal Cancer Audit group. Morbidity and mortality according to age following gastrectomy for gastric cancer. Br J Surg 2018; 105: 1163-70. https://doi.org/10.1002/bjs.10836
Dindo D, Demartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Li SS, Costantino CL, Mullen JT. Morbidity and mortality of total gastrectomy: a comprehensive analysis of 90-day outcomes. Gastrointest Surg 2019; 23: 1340-8. https://doi.org/10.1007/s11605-019-04228-7
Bartlett EK, Roses RE, Kelz RR, Drebin JA, Fraker DL, Karakousis GC. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery 2014; 156: 298-304. https://doi.org/10.1016/j.surg.2014.03.022
Selby LV, Vertosick EA, Sjoberg DD, et al. Morbidity after total gastrectomy: analysis of 238 patients. J Am Coll Surg 2015; 220: 863-71. https://doi.org/10.1016/j.jamcollsurg.2015.01.058
Papenfuss WA, Kukar M, Oxenberg J, et al. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 2014; 21: 3008-14. https://doi.org/10.1245/s10434-014-3664-z
Pacelli F, Papa V, Rosa F, et al. Four hundred consecutive total gastrectomies for gastric cancer: a single-institution experience. Arch Surg 2008; 143: 769-75. https://doi.org/10.1001/archsurg.143.8.769
Nelen SD, Bosscha K, Lemmens VEPP, et al. Morbidity and mortality according to age following gastrectomy for gastric cancer. Br J Surg 2018; 105: 1163-70. https://doi.org/10.1002/bjs.10836
Tegels JJW, Hulsewé KWE, Sosef MN, Stoot JHMB. Morbidity and mortality after total gastrectomy for gastric
malignancy: do not forget about geriatric frailty and nutrition. Surgery 2015; 157: 406-7. https://doi.org/10.1016/j.surg.2014.10.021
van Gestel YRBM, Lemmens VEPP, de Hingh IHJT, et al. Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients. Ann Surg Oncol 2013; 20: 371-80. https://doi.org/10.1245/s10434-012-2663-1
Shannon AB, Straker RJ, Fraker DL, Roses RE, Miura JT, Karakousis GC. Ninety-day mortality after total gastrectomy for gastric cancer. Surgery 2021; 170: 603-9. https://doi.org/10.1016/j.surg.2021.02.010
Li HT, Han XP, Su L, et al. Short-term efficacy of laparoscopy assisted vs open radical gastrectomy in gastric cancer. World J Gastrointest Surg 2014; 6: 59-64. https://doi.org/10.4240/wjgs.v6.i4.59
Xiong JJ, Nunes QM, Huang W, et al. Laparoscopic vs open total gastrectomy for gastric cancer: a meta-analysis. World J Gastroenterol 2013; 19: 8114-32. https://doi.org/10.3748/wjg.v19.i44.8114
Kelly KJ, Selby L, Chou JF, et al. Laparoscopic versus open gastrectomy for gastric adenocarcinoma in the West: a case-control study. Ann Surg Oncol 2015; 22: 3590-96. https://doi.org/10.1245/s10434-015-4381-y
Lu J, Huang CM, Zheng CH, et al. Short- and long-term outcomes after laparoscopic versus open total gastrectomy for elderly gastric cancer patients: a propensity score-matched analysis. J Gastrointest Surg 2015; 19: 1949-57. https://doi.org/10.1007/s11605-015-2912-2
Song JH, Choi YY, An JY Kim DW, Hyung WJ, Noh SH. Short-term outcomes of laparoscopic total gastrectomy performed by a single surgeon experienced in open gastrectomy: review of initial experience. J Gastric Cancer 2015; 15: 159-66. https://doi.org/10.5230/jgc.2015.15.3.159
Liu F, Huang C, Xu Z, et al. Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer The CLASS02 Multicenter Randomized Clinical Trial. JAMA Oncol 2020; 6: 1590-97. https://doi.org/10.1001/jamaoncol.2020.3152
Katai H, Mizusawa J, Katayama H, et al. Stomach Cancer Study Group of Japan Clinical Oncology Group. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer 2019; 22: 999-1008. https://doi.org/10.1007/s10120-019-00929-9
Hyung WJ, Yang HK, Han SU, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03. Gastric Cancer 2019; 22: 214-22. https://doi.org/10.1007/s10120-018-0864-4
- Downloads
- Published
- 2022-06-22
- Issue
- Vol. 11 (2022)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- D.A. Tzerkovsky, A.N. Mazurenko, D.I. Kozlovsky, F.F. Borychevsky, Radiodynamic Therapy with Chlorine-Based Photosensitizer on Pliss Lymphosarcoma Solid Tumor: In Vivo Experiment , Journal of Analytical Oncology: Vol. 11 (2022)
- Tatiana Levkovich, Theofilos Poutahidis, Kelsey Cappelle, Mark B. Smith, Allison Perrotta, Eric J. Alm , Susan E. Erdman , ‘Hygienic’ Lymphocytes Convey Increased Cancer Risk , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- A. Taqaddas, E-Survey: Current Status of Proton Beam Therapy in USA , Journal of Analytical Oncology: Vol. 10 (2021)
- T.G. Shrihari , Endorphins - A Novel Holistic Therapeutic Approach to Cancer , Journal of Analytical Oncology: Vol. 7 No. 3 (2018)
- Arunima Ghosh, Karlena Lara-Otero, Marston W. Linehan , Maria J. Merino , Can Mutations in the BAP1 Gene be Detected by Immunohisto-chemistry in Hereditary Kidney Cancers? , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Vivel Nambiar, Kirthi Koushik, Ram Charith Alva, Comparison of Thermoplastic Cast Versus Knee Wedge/Foot Rest Immobilization Technique in the Treatment of Carcinoma Cervix with Conformal Radiation Therapy , Journal of Analytical Oncology: Vol. 11 (2022)
- Vladimir Zaichick, Sofia Zaichick, Sinclair Wynchank, Intracellular Zinc Excess as One of the Main Factors in the Etiology of Prostate Cancer , Journal of Analytical Oncology: Vol. 5 No. 3 (2016)
- Robert Skopec, Mutagenesis Associated with DNA-Damage-Stress Response , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Antonieta Salud, Vicente Alonso, Pilar Escudero, Miguel Burillo, Cristina Martín, Fernando Rivera, Alfonso Yubero, Carlos García-Girón, Alberto Muñoz, Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Abigail Ruiz de Lobera, Aitziber Buqué, Alberto Muñoz, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Eddy I. Gutierrez, Mikel Arruti, Inés Marrodán, Guillermo López-Vivanco, Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
You may also start an advanced similarity search for this article.
